fbpx
August 18, 2021

FDA Warns Clinicians to Stop Using Eco-Med Products FDA Warns Clinicians to Stop Using Eco-Med Products

The US Food and Drug Administration (FDA) is urging healthcare providers to immediately stop use of and discard all Eco-Med ultrasound gels and lotions because of […]
August 17, 2021

FDA Approves Pfizer’s Tick-borne Encephalitis Vaccine FDA Approves Pfizer’s Tick-borne Encephalitis Vaccine

The US Food and Drug Administration (FDA) has approved Pfizer’s TicoVac vaccine for the treatment of tick-borne encephalitis (TBE). The vaccine is approved outside of United […]
August 17, 2021

Pfizer Recalls Four More Lots of Smoking Cessation Drug Chantix Pfizer Recalls Four More Lots of Smoking Cessation Drug Chantix

Pfizer has recalled four more lots of the smoking cessation drug varenicline (Chantix), according to an update on the US Food and Drug Administration (FDA) website. […]
August 17, 2021

FDA Approves Abbott’s Amplatzer Amulet for Atrial Fibrillation  FDA Approves Abbott’s Amplatzer Amulet for Atrial Fibrillation 

The US Food and Administration (FDA) has approved the Amplatzer Amulet left atrial appendage occluder (Abbott) to treat people with nonvalvular atrial fibrillation who are at […]
August 13, 2021

FDA OKs Belzutifan for Cancers Tied to von Hippel-Lindau Disease FDA OKs Belzutifan for Cancers Tied to von Hippel-Lindau Disease

The US Food and Drug Administration (FDA) approved belzutifan (Welireg) for adult patients with von Hippel-Lindau disease (VHL) who require therapy for associated renal cell carcinoma […]
August 12, 2021

FDA Approves First Drug for Idiopathic Hypersomnia FDA Approves First Drug for Idiopathic Hypersomnia

The US Food and Drug Administration (FDA) has approved an oral solution of calcium, magnesium, potassium, and sodium oxybates (Xywav) for the treatment of idiopathic hypersomnia […]
August 12, 2021

FDA OKs Pembro Plus Lenvatinib For First-Line in Kidney Cancer FDA OKs Pembro Plus Lenvatinib For First-Line in Kidney Cancer

The Food and Drug Administration (FDA) has approved the combination of pembrolizumab (Keytruda, Merck Sharp & Dohme) with lenvatinib (Lenvima, Eisai Inc) for the first-line treatment […]
August 10, 2021

EU Approves Dapagliflozin for Kidney Disease, Regardless of Diabetes EU Approves Dapagliflozin for Kidney Disease, Regardless of Diabetes

Dapagliflozin (Forxiga) has been approved for use in the European Union to treat adults with chronic kidney disease who do not have diabetes. It is the […]
August 6, 2021

FDA Clears Abbott’s AI-Powered Coronary Imaging Platform FDA Clears Abbott’s AI-Powered Coronary Imaging Platform

The US Food and Drug Administration has cleared Abbott’s latest optical coherence tomography (OCT) imaging platform powered by its new Ultreon Software, the company has announced. […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0